Roche acquiring Anadys for $3.70 per share in cash, or about $230M

Anadys Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$210.1m on 10/21/2011 [market cap]

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed